For HIV-positive individuals, combination antiretroviral therapy (ART) has been a lifesaving treatment, allowing people with HIV to have near-normal life expectancies. However, these patients may have a higher risk of developing diabetes than the general population, and at earlier ages. The risk is higher for those who took older formulations of ART, and for those who have been on the treatment for longer periods of time. Read more